Hill-Rom Holdings, Inc. logo
Hill-Rom Holdings, Inc. HRC

Hill-Rom Holdings, Inc. Gross Profit 2011-2026 | HRC

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
  • Raw materials and supplies
  • Wages of production personnel
  • Depreciation of equipment
  • Transportation and warehousing costs (if directly related to production)
Importance for business:
  • Assessing core business profitability
    If gross profit is declining, it may indicate rising production costs or falling sales.
  • Financial planning
    Gross profit is the basis for calculating other key metrics, such as operating and net profit.
  • Benchmarking against competitors
    Gross profit analysis helps compare the efficiency of different companies within the same industry.
  • Insights into pricing effectiveness
    If gross profit is low, the company may be pricing too low or failing to control costs effectively.
Reasons for a decline in gross profit:
  • Increase in raw material and supply costs
  • Rising production expenses
  • Price reductions due to competition
  • Decrease in sales volume
  • Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit Hill-Rom Holdings, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.48 B 1.42 B 1.39 B 1.32 B 1.26 B 880 M 780 M 780 M 755 M 781 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.48 B 755 M 1.08 B

Gross Profit of other stocks in the Medical instruments industry

Issuer Gross Profit Price % 24h Market Cap Country
Atrion Corporation Atrion Corporation
ATRI
62.4 K - - $ 810 M usaUSA
The Cooper Companies The Cooper Companies
COO
2.68 B $ 68.62 - $ 13.7 B usaUSA
Luminex Corporation Luminex Corporation
LMNX
248 M - - $ 1.75 B usaUSA
Glaukos Corporation Glaukos Corporation
GKOS
283 M $ 126.34 - $ 7.23 B usaUSA
Akers Biosciences, Inc. Akers Biosciences, Inc.
AKER
479 K - -9.52 % $ 20.6 M usaUSA
Alcon Alcon
ALC
5.74 B $ 67.9 - $ 40.4 B schweizSchweiz
Intuitive Surgical Intuitive Surgical
ISRG
6.64 B $ 426.61 - $ 152 B usaUSA
ICU Medical ICU Medical
ICUI
822 M $ 142.0 - $ 3.5 B usaUSA
iRhythm Technologies iRhythm Technologies
IRTC
527 M $ 113.83 - $ 3.64 B usaUSA
Repro Med Systems Repro Med Systems
KRMD
25.6 M $ 4.0 - $ 185 M usaUSA
Antares Pharma, Inc. Antares Pharma, Inc.
ATRS
86.5 M - - $ 955 M usaUSA
Cantel Medical Corp. Cantel Medical Corp.
CMD
436 M - -1.18 % $ 3.4 B usaUSA
CRH Medical Corporation CRH Medical Corporation
CRHM
1.68 M - - $ 282 M usaUSA
LeMaitre Vascular LeMaitre Vascular
LMAT
179 M $ 96.59 - $ 2.19 B usaUSA
Masimo Corporation Masimo Corporation
MASI
1 B $ 179.95 0.01 % $ 9.59 B usaUSA
Microbot Medical Microbot Medical
MBOT
117 K $ 1.82 - $ 83.3 M israelIsrael
Ekso Bionics Holdings Ekso Bionics Holdings
EKSO
6.84 M - - $ 28.6 M usaUSA
Milestone Scientific Milestone Scientific
MLSS
6.41 M $ 0.39 - $ 32 M usaUSA
Varian Medical Systems, Inc. Varian Medical Systems, Inc.
VAR
1.38 B - -0.02 % $ 16.3 B usaUSA
Merit Medical Systems Merit Medical Systems
MMSI
738 M $ 67.51 - $ 3.99 B usaUSA
electroCore electroCore
ECOR
27.8 M $ 9.52 -1.24 % $ 80.8 K usaUSA
Envista Holdings Corporation Envista Holdings Corporation
NVST
1.49 B $ 24.59 - $ 4.13 B usaUSA
Haemonetics Corporation Haemonetics Corporation
HAE
788 M $ 78.71 - $ 3.71 B usaUSA
Isoray Isoray
ISR
1.43 M - 0.03 % $ 108 M usaUSA
STERIS plc STERIS plc
STE
2.63 B $ 212.88 - $ 20.9 B usaUSA
STAAR Surgical Company STAAR Surgical Company
STAA
182 M $ 29.87 -0.3 % $ 1.48 B usaUSA
InfuSystem Holdings InfuSystem Holdings
INFU
80.3 M $ 9.01 - $ 186 M usaUSA
Utah Medical Products Utah Medical Products
UTMD
5.26 M $ 68.07 1.52 % $ 221 M usaUSA
Teleflex Incorporated Teleflex Incorporated
TFX
307 M $ 135.75 - $ 6.06 B usaUSA
West Pharmaceutical Services West Pharmaceutical Services
WST
1.1 B $ 334.66 - $ 24.2 B usaUSA
DENTSPLY SIRONA DENTSPLY SIRONA
XRAY
1.84 B $ 10.47 - $ 2.09 B usaUSA
Retractable Technologies Retractable Technologies
RVP
47 K $ 0.69 - $ 20.7 M usaUSA
Pro-Dex Pro-Dex
PDEX
19.5 M $ 65.0 - $ 214 M usaUSA
Predictive Oncology Predictive Oncology
POAI
6.53 K - - $ 31.1 M usaUSA
BioLife Solutions BioLife Solutions
BLFS
62.1 M $ 27.55 - $ 1.32 B usaUSA
Stereotaxis Stereotaxis
STXS
17.1 M $ 1.85 - $ 168 M usaUSA
Baxter International Baxter International
BAX
3.38 B $ 20.03 - $ 10.3 B usaUSA
ResMed ResMed
RMD
2.02 B $ 196.94 -0.02 % $ 28.8 B usaUSA
AtriCure AtriCure
ATRC
401 M $ 27.3 - $ 1.3 B usaUSA
Harvard Bioscience Harvard Bioscience
HBIO
49.9 M $ 6.04 - $ 268 M usaUSA
NeuroMetrix NeuroMetrix
NURO
1.68 M - 5.05 % $ 9.02 M usaUSA
AngioDynamics AngioDynamics
ANGO
158 M $ 12.34 3.44 % $ 504 M usaUSA
Becton, Dickinson and Company Becton, Dickinson and Company
BDX
8.29 B $ 152.04 - $ 43.7 B usaUSA
Nephros Nephros
NEPH
11.6 M $ 3.25 - $ 34.5 M usaUSA
OraSure Technologies OraSure Technologies
OSUR
48.2 M $ 4.24 2.17 % $ 312 M usaUSA
Repligen Corporation Repligen Corporation
RGEN
151 M $ 130.13 - $ 7.32 M usaUSA